Tobias Lämmle
Latest from Tobias Lämmle
Pharmaceutical business drives recovery: Bayer raises annual forecast after strong quarter
Forecast increase for 2026: Thanks to flourishing pharmaceutical businesses, Bayer raises its...
Opportunity after the correction: Deutsche Bank upgrades US technology stocks again
Revision after three weeks: Deutsche Bank ends its cautious stance and sees the recent sell-off...
Defense boom and record orders: Morgan Stanley sees 45% upside potential for L3Harris
Buy recommendation with a target price of 402 dollars: Morgan Stanley rates L3Harris as "Overweight"...
Surge in profits in the oil business: Chevron surpasses Wall Street estimates in the third quarter
Surge in profits and revenue growth: With revenue of $67.8 billion and earnings per share of $5.28,...
Pipeline with Billion-Dollar Potential: AstraZeneca Accelerates Growth Path Towards 2030
Strong Quarterly Results: In the third quarter, revenue increased to $16.21 billion, while core earnings...
GLP-1 Dynamics Continue: Eli Lilly Significantly Raises Revenue Forecast After Strong Quarter
Operational Record Numbers: In the third quarter, the company’s revenue rose to $24.4 billion,...
Billion-Dollar Deal in the Chip Sector: Marvell Negotiates Acquisition of Lumentum
Strategic Consolidation: Marvell Technology is in advanced talks to acquire the optical specialist...
AI Segment Ignites: ExlService Surpasses Market Estimates and Raises Annual Targets
Expectations Exceeded: In the third quarter of 2026, ExlService recorded a revenue of $633, 96...
Three Years Ahead of Plan: ASM International Raises Medium-Term Goals Thanks to AI Boom
Forecasts exceeded: ASM International aims for a revenue of 1, 23 billion euros in the fourth quarter,...
Key Technology for AI Processors: Applied Materials Expands Stake in Besi
Expansion of Engagement: Applied Materials increases its stake in BE Semiconductor Industries (Besi)...
Boom in AI Infrastructure: Celestica Exceeds Expectations and Significantly Raises Forecasts
Dynamic Quarterly Growth: Revenue climbed by 82.5% in the third quarter to $5.83 billion, while adjusted...
Hope bearer in oncology: Genmab impresses with Phase 2 data on Petosemtamab
Strong response rates: In combination with standard chemotherapy, Petosemtamab achieves response...
Important market success in Asia: Bayer receives approval for Xarelto successor in China
Strategic milestone: The Chinese authority NMPA approves the anticoagulant Asundexian under the...
Record Values in Building Technology: Comfort Systems USA Significantly Exceeds Analyst Expectations
Revenue and profit surge: Revenue increased by 50% year-over-year to $3.77 billion in the third...
Yield Surge in the Lab: How AI Agents are Empowering Contract Research in the Life Sciences Sector
Technological Shift: The practical testing of advanced AI models like "Claude Science" marks the...
Market discount in focus: US activist Ananym sees up to 100 percent potential in CTS Eventim
Significant undervaluation: Ananym sees up to 100% upside potential for CTS Eventim to close the...
From Construction to Computing Power: How the European Ecosystem Builds State-of-the-Art AI Factories with Nvidia DSX
Dramatic Time Savings: The new reference design Nvidia DSX POD reduces the deployment time of "Vera...
Strategic Workaround Purchases: Chinese Tech Giants Order Nvidia Chips Worth 35 Billion Dollars
Massive Order: ByteDance, Alibaba, and Tencent have ordered more than three million units of the...
Strategic Alliance in Neurotechnology: Siemens Healthineers Invests in the Brain Implant Market
Strategic Partnership: Siemens Healthineers forms an alliance with the US start-up Paradromics...
Strategic Direction Convincing: Goldman Sachs Sees Zeta Global on Cusp of Growth Surge
Significant Upgrade: Goldman Sachs upgrades the stock of Zeta Global from "Neutral" to "Buy" and...